Global burden of hypertensive heart disease reveals significant risk factors and changing mortality trends.
Background Hypertensive heart disease (HHD) remains a significant global health issue. Methods This study analysed the global, regional, and national burden of HHD from 1990 to 2021. Results In 2021, the global prevalence, deaths, and disability‐adjusted life years (DALYs) associated with HHD were 12.5 million, 1.3 million and 25.5 million, respectively, exhibiting age‐standardized percentage changes of 18.2%, −22.0% and −25.8% compared to 1990. Jordan (341.9), Bulgaria (103.4) and Bulgaria (1739.3) had the highest age‐standardized prevalence, death and DALY rates, respectively, while Belarus recorded the lowest rates. DALYs reached their zenith in the 70–74 age range, but age‐standardized DALY rates were rising in the oldest age group (≥95). A negative correlation was observed between the sociodemographic index and DALY rates. The key risk factors identified were high systolic blood pressure (100%), high BMI (49.3%) and insufficient fruit intake (37.8%). Conclusion Although case numbers have increased, age‐standardised death and DALY rates have declined since 1990. Targeted prevention strategies should prioritise blood pressure control, weight management and dietary measures to mitigate the burden of HHD.
No takes yet. Share an insight, caveat, or question.
Che et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: